D. Kvale

H. Rollag, L. Sandvik, A. Johannessen, 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.

F. O. Pettersen, D. Kvale, A. Maagaard, 2008, The Journal of infectious diseases.

Different regulatory pathways employed in cytokine‐enhanced expression of secretory component and epithelial HLA class I genes

P. Krajči, P. Brandtzaeg, F. Johansen, 1999, European journal of immunology.

Immunophenotypic analyses of CD34+ cell subsets in bone marrow from HIV‐infected patients during highly‐ active antiretroviral therapy

S. Frøland, P. Aukrust, O. Mellbye, 2002, European journal of clinical investigation.

Molecular cloning and exon‐intron mapping of the gene encoding human transmembrane secretory component (the poly‐Ig receptor)

P. Krajči, K. Taskén, P. Brandtzaeg, 1992, European journal of immunology.

An enzyme-linked immunosorbent assay for differential quantitation of secretory immunoglobulins of the A and M isotypes in human serum.

P. Brandtzaeg, D. Kvale, 1986, Journal of immunological methods.

Does secretory component (SC) exist as free SC in human serum?

P. Brandtzaeg, D. Kvale, 1988, Journal of immunological methods.

Reaction to the article: ELISA for measurement of secretory IgA distinct from monomeric IgA.

P. Brandtzaeg, D. Kvale, 1987, Journal of immunological methods.

Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.

O. Fodstad, A. Aasen, I. Kjønniksen, 1994, Anticancer research.

Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors

K. Taskén, D. Kvale, A. Dyrhol-Riise, 2015, PloS one.

Human Immunodeficiency Virus–Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction

M. Kummen, J. Hov, I. Seljeflot, 2020, The Journal of infectious diseases.

PD-1 predicts CD4 loss rate in chronic HIV-1 infection better than HIV RNA and CD38 but not in cryopreserved samples.

F. O. Pettersen, D. Kvale, M. Holm, 2008, Current HIV research.

CD4+ and CD8+ lymphocytes and HIV RNA in HIV infection: high baseline counts and in particular rapid decrease of CD8+ lymphocytes predict AIDS.

S. Frøland, P. Aukrust, K. Osnes, 1999, AIDS.

Prognostic Value of Nucleated RBCs for Patients With Suspected Sepsis in the Emergency Department: A Single-Center Prospective Cohort Study

E. K. Amundsen, O. Klingenberg, D. Kvale, 2021, Critical care explorations.

Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides

T. Ø. Jonassen, A. Kran, D. Kvale, 2010, AIDS.

Epithelial Expression of HLA, Secretory Component (Poly‐Ig Receptor), and Adhesion Molecules in the Human Alimentary Tract a

P. Krajči, H. Huitfeldt, T. Halstensen, 1992, Annals of the New York Academy of Sciences.

Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells.

P. Brandtzaeg, I. Farstad, P Brandtzaeg, 1996, Journal of immunology.

Butyrate differentially affects constitutive and cytokine-induced expression of HLA molecules, secretory component (SC), and ICAM-1 in a colonic epithelial cell line (HT-29, clone m3).

P. Brandtzaeg, D. Kvale, 1995, Advances in experimental medicine and biology.

IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection

M. Ruhwald, D. Kvale, A. Dyrhol-Riise, 2015, Scientific Reports.

Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients.

H. Rollag, M. Degré, K. Kristiansen, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment

E. Aandahl, K. Taskén, S. Frøland, 2006, AIDS.

T cell-epithelium interactions in relation to gut immunity.

E. Thorsby, L. Sollid, G. Gaudernack, 1988, Monographs in allergy.

Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years

I. Baksaas, A. Lind, D. Kvale, 2012, Scandinavian journal of infectious diseases.

Microbial Translocation in HIV Infection Is Associated With Dyslipidemia, Insulin Resistance, and Risk of Myocardial Infarction

S. Nielsen, C. Thomsen, M. Trøseid, 2013, Journal of acquired immune deficiency syndromes.

Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients

K. Taskén, J. Nigou, R. Mortensen, 2021, Frontiers in Cellular and Infection Microbiology.

Interleukin‐10‐secreting T cells define a suppressive subset within the HIV‐1‐specific T‐cell population

A. Jha, D. Nixon, K. Torgersen, 2009, European journal of immunology.

Circulating secretory component in breast neoplasms.

S. Fosså, T. Rognum, E. Thorud, 1987, Journal of clinical pathology.

Circulating secretory componentinbreast neoplasms

S. Fosså, E. Thorud, P. Brandtzaeg, 1987 .

A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients

Inge Christoffer Olsen, K. Taskén, R. Mortensen, 2021, Nature Communications.

HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)

J. Nyhus, Birger Sørensen, Ingebjørg Baksaas, 2004, AIDS.

Combined Env‐ and Gag‐specific T cell responses in relation to programmed death‐1 receptor and CD4+ T cell loss rates in human immunodeficiency virus‐1 infection

K. Taskén, F. O. Pettersen, D. Kvale, 2010, Clinical and experimental immunology.

Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy

A. Lind, D. Kvale, Christian Prebensen, 2016, PloS one.

Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanisms.

H. Aass, I. Baksaas, A. Lind, 2013, Vaccine.

Delayed‐type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide‐based therapeutic immunization for chronic HIV infection

A. Kran, I. Baksaas, D. Kvale, 2012, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Cloning, chromosomal localization, and linkage analysis of the gene encoding human transmembrane secretory component (the poly-Ig receptor).

P. Krajči, P. Brandtzaeg, D. Kvale, 1995, Advances in experimental medicine and biology.

Circulating secretory immunoglobulins of the A and M isotypes in chronic liver disease.

E. Schrumpf, H. E. Solberg, P. Brandtzaeg, 1987, Journal of hepatology.

Microbial translocation and cardiometabolic risk factors in HIV infection.

S. Nielsen, M. Trøseid, D. Kvale, 2014, AIDS research and human retroviruses.

Mortality and Sequential Organ Failure Assessment Score in Patients With Suspected Sepsis: The Impact of Acute and Preexisting Organ Failures and Infection Likelihood

R. Hoff, D. Kvale, Christian Prebensen, 2023, Critical care explorations.

Clinical characteristics and outcomes in hospitalized adult influenza patients: an observational study from Norway 2014–2018

S. Mjaaland, F. Oftung, G. Tunheim, 2022, Infectious diseases.

Predictive Value of Immunologic Parameters and HIV RNA in Relation to Humoral Pneumococcal Polysaccharide Vaccine Responses in Patients with HIV Infection

S. Frøland, I. Aaberge, D. Kvale, 2002, European Journal of Clinical Microbiology and Infectious Diseases.

Brief Report: Insulin Resistance Is Affected by Increased Levels of Plasma Lactate but not Mitochondrial Alterations in Skeletal Muscle in NRTI-Exposed HIV-Infected Patients

P. Torjesen, J. Bruun, D. Kvale, 2007, HIV clinical trials.

Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART

P. Ueland, K. Rudi, P. Sandset, 2015, Journal of acquired immune deficiency syndromes.

A web-based intervention trial for depressive symptoms and subjective well-being in patients with chronic HIV infection

P. Kraft, F. Drozd, D. Kvale, 2014, AIDS care.

Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4+ T Cells in HIV-Infected Immunological Non-Responders

K. Taskén, M. Lund-Iversen, A. Medhus, 2021, Frontiers in Immunology.

Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization.

J. Nyhus, A. Kran, J. Bruun, 2005, Vaccine.

Immune modulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human hepatocytic cell lines.

P. Brandtzaeg, D. Kvale, 1993, Journal of hepatology.